Suppr超能文献

表没食子儿茶素没食子酸酯对叔丁基过氧化氢诱导的肝损伤中衰老标记蛋白-30的上调和稳定作用及……(原文此处不完整)

Upregulation and stabilization of senescence marker protein-30 by epigallocatechin gallate against -butyl hydroperoxide-induced liver injury and .

作者信息

Inoue Hirofumi, Arakawa Kohta, Tanaka Miori, Katsumata-Tsuboi Rie, Takahashi Nobuyuki, Uehara Mariko

机构信息

Department of Nutritional Science and Food Safety, Faculty of Applied Bioscience, Tokyo University of Agriculture, 1-1-1 Sakuragaoka, Setagaya-ku, Tokyo 156-8502, Japan.

出版信息

J Clin Biochem Nutr. 2021 Jan;68(1):51-57. doi: 10.3164/jcbn.20-119. Epub 2020 Nov 14.

Abstract

Senescence marker protein-30 (SMP30), a novel ageing marker, suppresses oxidative stress in the liver. However, studies on phytochemical-mediated regulation of SMP30 expression are lacking. Here, we showed that epigallocatechin gallate (EGCg), a polyphenol abundant in green tea, positively regulates SMP30 expression in the rat hepatoma-derived Fao cells. EGCg maintained SMP30 expression even in the presence of cycloheximide, a protein synthesis inhibitor. Furthermore, treatment of cells with -butyl hydroperoxide (-BHP), an oxidative promoter, decreased SMP30 expression and ERK1/2 phosphorylation, while EGCg treatment inhibited these effects. Male mice (7-week-old) were divided into 4 groups-Control (saline), -BHP (1.5 mmol/kg -BHP), EGCg + -BHP (30 mg/kg/day of EGCg and 1.5 mmol/kg -BHP), and EGCg (30 mg/kg/day). After oral EGCg administration for 6 consecutive days, EGCg + -BHP group mice were administered -BHP. The -BHP-administered mice showed decreased SMP30 expression in the liver and increased aspartate aminotransferase and alanine transaminase (hepatic injury marker enzymes) activities; however, EGCg treatment attenuated these changes. Thus, EGCg-induced SMP30 upregulation may alleviate -BHP-induced liver injury. The findings of this study offer new perspectives of the anti-ageing properties of EGCg.

摘要

衰老标志物蛋白-30(SMP30)是一种新型衰老标志物,可抑制肝脏中的氧化应激。然而,关于植物化学物质介导的SMP30表达调控的研究尚属空白。在此,我们发现表没食子儿茶素没食子酸酯(EGCg),一种绿茶中富含的多酚,可正向调控大鼠肝癌衍生的Fao细胞中SMP30的表达。即使在存在蛋白质合成抑制剂环己酰亚胺的情况下,EGCg仍能维持SMP30的表达。此外,用氧化促进剂叔丁基过氧化氢(t-BHP)处理细胞会降低SMP30的表达和ERK1/2磷酸化,而EGCg处理可抑制这些作用。将雄性小鼠(7周龄)分为4组——对照组(生理盐水)、t-BHP组(1.5 mmol/kg t-BHP)、EGCg + t-BHP组(30 mg/kg/天的EGCg和1.5 mmol/kg t-BHP)和EGCg组(30 mg/kg/天)。连续口服EGCg 6天后,给EGCg + t-BHP组小鼠注射t-BHP。注射t-BHP的小鼠肝脏中SMP30表达降低,天冬氨酸转氨酶和丙氨酸转氨酶(肝损伤标志物酶)活性升高;然而,EGCg处理减轻了这些变化。因此,EGCg诱导的SMP30上调可能减轻t-BHP诱导的肝损伤。本研究结果为EGCg的抗衰老特性提供了新的视角。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73ac/7844653/11650fe6ee1c/jcbn20-119f01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验